Progressive hyperleukocytosis is a relevant predictive marker for differentiation syndrome, early death, and subsequent relapse in acute promyelocytic leukemia.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
15 08 2019
Historique:
received: 23 11 2018
accepted: 22 07 2019
entrez: 17 8 2019
pubmed: 17 8 2019
medline: 22 10 2020
Statut: epublish

Résumé

Acute promyelocytic leukemia (APL) is generally held to have favorable risk, but we have observed a high incidence of early deaths caused by fatal bleeding and differentiation syndrome (DS). We retrospectively analyzed 259 APL patients from 2002 to 2014 who all received all-trans retinoic acid (ATRA) with the support of sufficient transfusions, followed by 4 days of idarubicin. High-risk status was determined as a diagnostic leukocyte count (WBCdx) >10 × 10

Identifiants

pubmed: 31417123
doi: 10.1038/s41598-019-47937-4
pii: 10.1038/s41598-019-47937-4
pmc: PMC6695497
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11935

Références

Blood. 1999 Nov 1;94(9):3015-21
pubmed: 10556184
Blood. 2017 Mar 9;129(10):1275-1283
pubmed: 28003274
Blood. 2008 Apr 1;111(7):3395-402
pubmed: 18195095
Blood. 2011 Aug 4;118(5):1248-54
pubmed: 21653939
J Clin Oncol. 2017 Feb 20;35(6):605-612
pubmed: 27400939
Blood. 2000 Aug 15;96(4):1247-53
pubmed: 10942364
Leukemia. 2014 Dec;28(12):2422-4
pubmed: 25142818
Ann Hematol. 2016 Apr;95(5):673-80
pubmed: 26920716
Blood. 2008 Oct 15;112(8):3130-4
pubmed: 18664623
N Engl J Med. 2013 Jul 11;369(2):111-21
pubmed: 23841729
J Clin Oncol. 2006 Dec 20;24(36):5703-10
pubmed: 17116939
Blood. 1998 Oct 15;92(8):2712-8
pubmed: 9763554
Leukemia. 2003 Jun;17(6):1085-90
pubmed: 12764372
Blood. 1997 Aug 1;90(3):1014-21
pubmed: 9242531
J Clin Oncol. 2014 Oct 20;32(30):3406-12
pubmed: 25245446
Blood. 2004 Feb 15;103(4):1237-43
pubmed: 14576047
Curr Opin Hematol. 2016 Mar;23(2):127-36
pubmed: 26825698
Haematologica. 2006 May;91(5):671-4
pubmed: 16627255
Blood. 2009 Jan 22;113(4):775-83
pubmed: 18945964
Blood. 2010 Jun 24;115(25):5137-46
pubmed: 20393132
Ann Oncol. 2016 Aug;27(8):1474-81
pubmed: 27084953
Blood. 2010 Jul 22;116(3):354-65
pubmed: 20385793
Blood. 1994 Dec 1;84(11):3843-9
pubmed: 7949141
J Hematol Oncol. 2017 Jan 23;10(1):30
pubmed: 28114959

Auteurs

Jae-Ho Yoon (JH)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Hee-Je Kim (HJ)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. cumckim@catholic.ac.kr.

Gi June Min (GJ)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Sung-Soo Park (SS)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Young-Woo Jeon (YW)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Sung-Eun Lee (SE)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Byung-Sik Cho (BS)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Ki-Seong Eom (KS)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Yoo-Jin Kim (YJ)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Seok Lee (S)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Chang-Ki Min (CK)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Seok-Goo Cho (SG)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Jong Wook Lee (JW)

Department of Hematology, Catholic Hematology Hospital and Leukemia Research Institute, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH